Press Releases
WASHINGTON, D.C. – Today, CongresswomanDoris Matsui (CA-07),Ranking Member of the House Energy and Commerce Subcommittee on Communications and Technology, released new, updated state-by-state data from the Federal Communications Commission (FCC) on theSecure and Trusted Communications Networks Reimbursement Program (SCRP).
WASHINGTON, D.C. – Today, CongresswomanDoris Matsui (CA-07),Ranking Member of the House Energy and Commerce Subcommittee on Communications and Technology, introduced the Stop Scams and Spam Act, legislation that would direct the Federal Communications Commission (FCC) to develop a tracking system to monitor and publish the top 100 illegal robocall and robotext campaigns.
SACRAMENTO, CA – An infusion of $1,000,000 in funds is headed to the Sacramento Native American Health Center’s (SNAHC) Florin Road expansion thanks to federal funding secured by Congresswoman Doris Matsui (CA-07). She announced the funding this morning alongside local leaders.
WASHINGTON, D.C. – Today, Congresswoman Doris Matsui (CA-07) issued the following statement after the Centers for Medicare & Medicaid Services (CMS) announced their Innovation in Behavioral Health (IBH) Model to improve the overall quality of care and outcomes for adults with mental health conditions and/or substance use disorder.
WASHINGTON, D.C. – CongresswomanDoris Matsui (CA-07) and Congressman Maxwell Alejandro Frost (FL-10) introduced the Epinephrine’s Pharma Inflated Price Ends Now Act (EPIPEN Act), legislation that would cap the out-of-pocket costs of epinephrine auto-injectors at just $60 per pack of two. Epinephrine auto-injectors, like EpiPens, are used to treat severe allergic reactions. This cap would apply to individuals with private health insurance.
WASHINGTON, D.C. – Today, Congresswoman Doris Matsui (CA-07) and Reps. Debbie Dingell (MI-06) and Kathy Castor (FL-14) led a group of 49 lawmakers in sending a letter to House and Senate Appropriations leadership, urging them to reject appropriations provisions that would gut new energy efficiency standards.
WASHINGTON, D.C. – Today, Congresswoman Doris Matsui (D-CA) and Congressman Larry Bucshon, M.D. (R-IN) introduced the Mapping America’s Pharmaceutical Supply (MAPS) Act, a bill to help the federal government prepare for and mitigate future drug shortages by identifying pharmaceutical supply chain vulnerabilities.
“Three years ago today, a violent mob – incited by former President Trump, stormed our citadel of democracy in an attempt to overturn our democratic process,” said Congresswoman Matsui. “President Trump’s false claims of election fraud, promotion of misinformation, and rampant demagoguery had dire consequences. As a result of that day’s horrific violence, brave capitol police officers lost their lives, with many more seriously injured.
WASHINGTON, D.C. – Congresswoman Doris Matsui (CA-07) and Congressman Earl L. “Buddy” Carter (GA-01) sent a letter to Drug Enforcement Administration (DEA) Administrator Anne Milgram voicing support for the agency’s temporary rules allowing patients to continue to be prescribed controlled substances via telemedicine, as clinically appropriate. They also advocated for swift issuance of a final rule that fulfills DEA’s mission while prioritizing patient access.
WASHINGTON, D.C. – Today, Congresswoman Doris Matsui (D-CA) and Congressman Michael McCaul (R-TX), co-authors of the Creating Helpful Incentives for the Production of Semiconductors (CHIPS) for America Act, issued the following statement after the first CHIPS Act Preliminary Memorandum of Terms was issued by the Commerce Department.